12:00 AM
 | 
Mar 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BEMA Buprenorphine: Preliminary Phase I data

Preliminary data from a placebo- and active-controlled Phase I trial in 14 healthy volunteers showed that 2 formulations of BEMA Buprenorphine produced measureable buprenorphine plasma concentrations...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >